Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Preparation and biological evaluation of 18F-VUIIS1008 for TSPO targeted imaging

Chao Ma, Liangliang Wang, Wentao Dong, Zhide Guo and Xinhui Su
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 335;
Chao Ma
2Zhongshan Hospital Xiamen University Xiamen China
3Zhongshan Hospital Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liangliang Wang
2Zhongshan Hospital Xiamen University Xiamen China
3Zhongshan Hospital Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wentao Dong
5Zhongshan Hospital Xiamen University, Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhide Guo
1Center for Molecular Imaging and Translational Med Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinhui Su
4Department of Nuclear Medicine Zhongshan Hospital Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

335

Objectives: To prepare a novel radiolabeled TSPO ligand 2-(5,7-Diethyl-2-(4-(2-[18F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide (18F-VUIIS1008) and evaluate its biological properties.

Methods: The tosylate substrate was labeled with fluorine-18 at its 2-fluoroethylmoiety using a tosyloxy-for-fluorine nucleophilic aliphatic substitutionlabeled to obtain 18F-VUIIS1008. The labeling efficiency, radiochemical purity, lipophilicity and stability were determined in vitro. In vitro cellular uptake and competitive binding assays were performed on RAW264.7 macrophage cells. Micro-PET imaging were investigated on Complete Freund’s Adjuvant-Induced Left Arthritis in mice. Results The labeling yields and radiochemical purity of 18F-VUIIS1008 were (41±5) % and more than 98 %, respectively. Lipophilicity was 1.58±0.03 and specific radioactivity was 4107 Ci/mmol. 18F-VUIIS1008 displayed good stability, which the radiochemical purity was more than > 98%, in saline at 4 h. It also exhibited high specific TSPO binding in RAW264.7 macrophage cells in vitro. The uptake ratio was (14.0 ± 0.3) % at 1 h after incubation, and decreased significantly after adding cold ligand (Figure 1). The competitive binding study showed that18F-VUIIS1008 has high affinity for TSPO with IC50 0.05nM (Figure 2). Micro-PET imaging demonstrated uptake of 18F-VUIIS1008 on the left arthritic ankles was gradually increased from 0.5 h to 1 h, which was (1.33±0.01)% ID/g at 1 h. The uptake was 2-2.5 times compared with contralateral normal ankles. The uptake of 18F-VUIIS1008 Micro PET imaging showed different levels at various days in inflammation models, with a peak of inflammation at day 7 and 29 (Fifure 3), suggesting that it was associated with the mechanism that the inflammation model was performed by CFA. 18F-VUIIS1008 Uptake in the arthritic ankles could be largely blocked by PK11195 or cold ligand (VUIIS1008) (Figure 4). Conclusion 18F-VUIIS1008 can be readily radiolabelled, clearly visualized arthritis and exhibited low background, suggesting its potential as a novel promising molecular probe targeting TSPO for arthritic PET imaging. [Key words] TSPO (translocator protein, 18 kDa); Isotope labeling; Fluorine-18 radioisotope; PET imaging; Arthrophlogosis

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preparation and biological evaluation of 18F-VUIIS1008 for TSPO targeted imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preparation and biological evaluation of 18F-VUIIS1008 for TSPO targeted imaging
Chao Ma, Liangliang Wang, Wentao Dong, Zhide Guo, Xinhui Su
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 335;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preparation and biological evaluation of 18F-VUIIS1008 for TSPO targeted imaging
Chao Ma, Liangliang Wang, Wentao Dong, Zhide Guo, Xinhui Su
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 335;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Preclinical Probes for Cardiovascular, Endocrine & Other II

  • Nanoparticle PET imaging of NPRC receptor in brown adipose tissue
  • Synthesis and evaluation of N-18F-fluorodeoxyglycosyl aminohippuric as a novel PET renal agent
  • Preparation and imaging of arthritis of 99Tcm-DTPA-CB86 for TSPO targeted imaging
Show more Preclinical Probes for Cardiovascular, Endocrine & Other II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire